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Abstract
Background: Type II alveolar epithelial cells (AT2) play a pivotal role in maintaining the integrity and function of
the alveoli. Only recently, the role of impaired epithelial repair mechanisms after injury in the pathogenesis of
idiopathic pulmonary fibrosis has been demonstrated, and has shifted the AT2 cell in the focus of interest. Therefore,
using primary human AT2 cells instead of cell lines for in vitro experiments has become desirable. Several groups have
developed methods to isolate human AT2 cells applying tissue digestion and consecutive filtration in their protocols.
Here we present a technique to isolate primary human AT2 cells by sprouting directly from peripheral human
lung tissue.
Methods: Epithelial cell cultures were established from lung tissue obtained from patients undergoing diagnostic or
therapeutic video-assisted thoracoscopic surgery or undergoing flexible bronchoscopy with transbronchial biopsy.
Lung tissue was cut into small pieces and those were placed into cell culture flasks containing supplemented epithelial
growth medium for cell sprouting. Cells were characterized by immunofluorescence stainings for E-cadherin, pan-
cytokeratin, surfactant protein C (SP-C), and for lysotracker; fluorescent surfactant associated protein B (SP-B) uptake and
secretion was assessed by live cell imaging; RNA levels of SP-A, SP-B, SP-C, and SP-D were determined by real-time PCR;
Electron microscopy was used to search for the presence of lamellar bodies.
Results: Sprouting of cells started two to four days after the start of culture. Epithelial differentiation was confirmed by
positive staining for E-cadherin and pan-cytokeratin. Further characterization demonstrated positivity for the AT2
cell marker SP-C and for lysotracker which selectively labels lamellar bodies in cultured AT2 cells. The up-take and
release of SP-B, a mechanism described for AT2 cells only, was demonstrated by live cell imaging. Real-time RT-
PCR showed mRNA expression of all four surfactant proteins with highest levels for SP-B. The presence of lamellar bodies
was demonstrated by electron microscopy.
Conclusions: This study describes a novel method for isolating AT2 cells from human adult lung tissue by sprouting. The
characterization of the cultured AT2 cells complies with current criteria for an alveolar type 2 cell phenotype. Compared
to current protocols for the culture of AT2 cells, isolating the cells by sprouting is simple, avoids proteolytic tissue
digestion, and has the advantage to be successful even from as few tissue as attained from a transbronchial forceps biopsy.
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To the editor
The lung alveolar epithelium comprises two types of
specialized epithelial cells, the alveolar epithelial type I
cells (AT1), that cover approximately 93% of the alveolar
surface area and through which gas exchange takes
place, and the type II alveolar epithelial cells (AT2) that
constitute 60% of lung alveolar cells and are the produ-
cer of the different surfactant proteins [1–3]. AT2 cells
play a pivotal role in maintaining the integrity and func-
tion of the alveoli and serve as progenitor of AT1 cells
[4–6]. Lung injury by agents such as cigarette smoke, vi-
ruses, and environmental particles mainly target the
alveolar epithelium [7], emphasizing its role for tissue
homeostasis [5]. Only recently, the role of impaired re-
pair mechanisms after injury in the pathogenesis of idio-
pathic pulmonary fibrosis has been demonstrated [8, 9],
and has shifted the AT2 cell in the focus of interest.
Therefore, using primary human AT2 cells instead of
cell lines (e.g. A549 epithelial cells) for in vitro experi-
ments has become desirable. Several groups have devel-
oped methods to isolate human AT2 cells, all applying
tissue digestion (using trypsin or elastase) and consecu-
tive filtration in their protocols [10–13]. Here we present
a technique to isolate primary human AT2 cells by
sprouting directly from peripheral human lung tissue.
Materials and methods
Ethical approval
Human lung tissue was obtained with approval of the Hu-
man Ethics Committee of the University of Basel (EKBB
05/06) and written informed consent was obtained from
all patients who underwent lung biopsy.
Patients
Epithelial cell cultures were established from lung tissue
obtained from patients undergoing diagnostic or thera-
peutic video-assisted thoracoscopic surgery (VATS) per-
formed at the Division of Thoracic Surgery or undergoing
flexible bronchoscopy with transbronchial biopsy at the
Clinics of Respiratory Medicine, University Hospital Basel,
Switzerland. In patients with lung tumors, lung tissue for
cell culture was obtained from the macroscopically normal
part away from the tumor.
Cell culture
Lung tissue was cut into small pieces and those were
placed into cell culture flasks for cell sprouting con-
taining supplemented epithelial growth medium
(Cnt-17) (CELLnTEC Advanced Cell System AB; Bern,
Switzerland). AT2 cells were grown under standard
conditions (37 °C, 21% O2, 5% CO2). Complete
epithelial culture medium was replaced every fourth
day. All experiments were performed using non-pas-
saged cells. Primary human lung fibroblasts cultured
in DMEM/10% FCS were used as negative controls
[14].
Immunofluorescence stainings in cultured cells
Immunofluorescence analysis of AT2 cells or fibro-
blasts was performed as previously described [15]:
cells were fixed with 4% formalin (10 min), and
permeabilized with methanol/acetic acid (3:1, ice-cold,
10 min). Cells were blocked with 5% BSA (1 h), and
then incubated with TRIC-Phalloidin (Sigma) for 1 h
at room temperature or antibodies against E-cadherin
(Abcam, Santa Cruz, LabForce AG), pan-cytokeratin
(Sigma-Aldrich, USA), calponin (Abcam), surfactant
protein C (SP-C) (ThermoFisher Scientific), overnight
at 4 °C in moist box; for LysoTracker® Green DND-26
(Cell Signaling Technologies, USA) cells were incu-
bated for 30 min at 37 degree. The primary antibodies
were detected by addition of Alexa Fluor 488 donkey
anti-rabbit, Alexa Fluor 594 goat anti-rabbit or Alexa
Fluor donkey anti-mouse IgG (all ThermoFisher
Scientific) for 1 h. To visualise the nuclei 4,6-diami-
do-2-phenylindole (Sigma) was added (5 min) and
cells were subsequently examined on a fluorescence
microscope Leica DMI4000B (Leica, Germany).
Live cell imaging
For live cell imaging of fluorescent surfactant associated
protein B (SP-B)uptake and secretion, 10 μg of recom-
binant SP-B (Cloud-Clone Corp, USA) was labelled
using BODIPY® FL NHS Ester (ThermoFischer, USA) as
described [16] and incubated in a 5% CO2 environment.
8 μg/ml of the resulting fluorescent SP-B were added to
each well for 30 min and then rinsed with PBS. The first
baseline picture was taken. Later, 100 μM of a diacyl-
glycerol analog (DAG; 1-Oleoyl-2-acetyl-sn-glycerol;
Sigma Aldrich,USA) was added and pictures were taken
after 5, 15 and 30 min using a Leica DMI4000B (Leica,
Germany). The fluorescence intensity was quantified
using Image J software (NIH, USA), and data is pre-
sented as mean fluorescence intensity.
Real-time RT-PCR
Total RNA was extracted from AT2 cells with a
Quick-RNA MiniPrep Kit (ZymoResearch, Orange,
CA) from four different epithelial cell lines. RNA
levels were determined by real-time PCR using an
SP-A (Hs00831305_s1), SP-B (Hs01090667_m1), SP-C
(Hs00161628), SP-D (Hs01108490_m1), or GAPDH
(Hs03929097_g1) TaqMan® Gene Expression Assay (all
Applied Biosystems, Foster City, CA). Samples were
run at 50 °C for 2 min, 1 cycle; 95 °C for 10 min,
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1 cycle; 95 °C for 15 s, 60 °C for 1 min, 40 cycle and
quantified by the ΔΔCt calculation method.
Electron microscopy
Cells were grown to confluency in 6-well plates and
were fixed with 2.5% glutaraldehyde in 0.15 M Hepes
buffer (707 mOsm, pH 7.4) and stored in the fixative
solution. The cells were further rinsed with the same
fixative and postfixed for 1 h with a solution of
0.1 M sodium cacodylate buffer with 1% solution of
osmium teratoxide (369 mOsm, pH 7.4). After rinsing
with 0.05 M maleate buffer (pH 5.0), cells were again
postfixed in a solution of 0.05 M maleate buffer con-
taining 0.5% uranyl acetate. After 1 h of incubation,
cells were dehydrated in consequently increasing con-
centrations of ethanol (70%, 80%, 96%, 100%) and
then left in a mixture of ethanol and epon (1:1) over-
night. On the following day, cells were embedded in
epon resin and left to polymerize at 60 °C for 6 days.
Ultrathin sections (70 nm) were cut with a Reichert-
Jung Ultracut E microtome, put on formyar coated
2 mm × 1 mm single slot copper grids and double
stained with 1% uranyl acetate and 3% lead citrate.
EM pictures were taken with the Philips EM 400 trans-
mission electron microscope, using Morada digital camera
and iTEM/cell^F program.
Western blot
Alveolar epithelial cells from two different donors were
used (i.e. sample-1 and sample-2). The cells were lysed
with Pierce IP lysis buffer (Thermo Fischer Scientific,
Waltham, MA, USA) according to the manufacturer’s
specifications. Protein content was analyzed with Bradford
assay (BIO-RAD, Hercules, CA, USA) as described in the
manufacturer’s protocol. 10 μL of loading buffer (LI-COR,
Lincoln, NE, USA) containing 10% β-Mercapto-ethanol
(Sigma-Aldrich, St Louis, MI, USA) were added to the
samples and incubation at 95 °C for 5 min followed. Sam-
ples were shortly centrifuged and were loaded on 12% gels
(BIO-RAD, Hercules, CA, USA). A protein molecular
weight marker was added (LI-QOR, Lincoln, NE, USA).
Gel electrophoresis was performed for 20 min at 80 V and
1 h at 150 V. Gels were transferred to Nitrocellulose
membranes (BIO-RAD) by Trans-Blot Turbo Transfer
System (BIO-RAD). B-actin (LI-QOR, Lincoln, NE, USA)
was used as a control. SP-C (Santa Cruz Biotechnology,
Santa Cruz, CA, USA) and β–Actin were added at 1:1000
dilutions and gels were incubated overnight at 4 °C, pro-
tected from light with gentle shaking. Gels were washed
and incubated with secondary antibodies for 1 h in the
dark at room temperature. Secondary antibodies were
purchased from LI-COR (IRDye-680RD and IRDye-
800RD) and visualization was done with a LI-COR Odys-
sey scanner.
Measurement of secreted phospholipids
AT2 cells were serum deprived for 24 h. The cell super-
natants were collected and centrifuged at 1200 rpm for
10 min. Epithelial growth media was used as control.
Phospholipid secretion was measured by a Phospholipid
Assay Kit (Sigma, Aldrich USA) according to the manu-
facturer’s instructions and data were expressed as con-
centration of phospholipids in μM.
Results
Sprouting of cells started two to four days after the start
of culture (Fig. 1a). Cells grew in a monolayer exhibiting a
typical cobblestone morphology (Fig. 1b and c). Epithelial
differentiation was confirmed by positive staining for the
epithelial markers E-cadherin and pan-cytokeratin (Fig. 1d
and e) and the absence of the mesenchymal cell marker
calponin (Fig. 1f). Further characterization by immuno-
fluorescence stainings demonstrated positivity for the AT2
cell marker SP-C (Fig. 1g) and for lysotracker which se-
lectively labels lamellar bodies in cultured AT2 cells [17,
18] (Fig. 1h). Outgrowth of fibroblasts is observed in very
rare cases and can be easily detected by the typical spindle
shaped morphology of fibroblasts (Fig. 1i and j), the pres-
ence of the mesenchymal marker calponin (Fig. 1k), and
the absence of the epithelial marker E-Cadherin (Fig. 1l)
and AT2 cell marker SP-C (Fig. 1m).
In addition, the up-take and release of SP-B was stud-
ied in the cells, a mechanism described for AT2 cells
only [19–24]. After incubation with labelled SP-B, a
first uptake was observed at 0 min (Fig. 2A, a), visual-
ized as green staining in the cytoplasm. Addition of a
surfactant secretagogue (1-oleoyl-2-acetyl-sn-glycerol)
resulted in a significant and time-dependent secretion
of SP-B, which was measured by a decrease in fluores-
cence intensity (Fig. 2A, b). Five minutes after addition,
a significant decrease in the fluorescence was detected,
and after 15 and 30 min the intensity of fluorescence
further diminished (Fig. 2A, b-f ). The secretion of
phospholipids, the main component of surfactant, was
detected in cell supernatants of AT2 cells (Fig. 2b). Fur-
thermore, gene expression of surfactant proteins A, B,
C, and D was studied by real-time RT-PCR, showing
mRNA expression of all four proteins with highest
levels for SP-B (Fig. 2c). In addition, the protein expres-
sion of SP-C was confirmed by western blot analysis
(Fig. 2d). Finally, the presence of lamellar bodies, a spe-
cific feature of AT2 cells, was demonstrated in the cells
using electron microscopy (Fig. 2e).
AT2 cell isolation by sprouting from a 1–2 mm piece of
peripheral lung tissue resulted in an average yield of 59.5 ×
103 ± 12.0 × 103 AT2 cells/tissue piece (n = 4 different lung
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tissue donors) after 7 days of culture. Potential trans-
differentiation into AT1 cells was assessed by repeated
SP-C immunofluorescence stainings: AT2 phenotype
persisted for at least 7 days after start of culture;
After 14 days, intensity of SP-C staining decreased
(data not shown).
Discussion
Here we report a technique to isolate primary human
AT2 cells by sprouting directly from peripheral hu-
man lung tissue. The cells exhibited the typical
cobblestone morphology of alveolar epithelial cells,
expressed all four surfactant proteins, had the ability
to take up and release SP-B, and showed ultrastruc-
tural evidence of lamellar bodies.
Using primary human AT2 cells in biomedical research
is of utmost importance due to the lack of reliably repre-
sentative cell lines. A549 human lung adenocarcinoma
epithelial cells are often used as a model for studying the
function of AT2 cells. However, whereas the cells exhibit
some characteristics of AT2 cells, they do not express sur-
factant proteins [10, 25] and have different cellular pheno-
types as compared to AT2 cells [26].
In contrast to previously published methods for cul-
turing AT2 cells, the here described protocol does
without initial tissue digestion by trypsin or elastase
[10–13], but works by direct cell sprouting from the
edge of the tissue. This might prove an advantage of
the here presented method, as the use of proteolytic
enzymes may alter certain cellular functions or recep-
tor expressions of isolated cells, as demonstrated by
trypsin-induced down-regulation of cell adhesion pro-
teins [27–29]. Furthermore, the here presented
method allows the culture of AT2 cells starting with
as few tissue (approximately 1 mm3) as attained from
a transbronchial forceps biopsy. In contrast, culture
protocols applying tissue digestion and filtration
require/start with tissue quantities between 10 g and
whole lung lobes [10, 13, 30, 31]. If studying rare dis-
eases such as idiopathic pulmonary fibrosis, access to
Fig. 1 Representative phase contrast pictures of primary human type II alveolar epithelial (AT2) cells (a, b) and primary human lung fibroblasts (i).
Phalloidin stainings visualizing the actin cytoskeleton of AT2 (c) and fibroblasts (j). Immunostainings for E-cadherin (d, l), pan-cytokeratin (e),
calponin (f, k), surfactant protein C (g, m), and for lysotracker (h)
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lung tissue derived from surgical lung biopsies is
scarce, and therefore, establishing AT2 cell cultures
from transbronchial biopsies is advantageous.
According to recently proposed criteria for the iden-
tification of AT2 cells [32], expression of key markers
including SP-A, SP-B, SP-C, SP-D and lysotracker was
positive in the above described cells. While mRNA for
SP-A, SP-B, and SP-D can be found in non-ciliated
bronchiolar cells [33], SP-C is the only AT2 cell–spe-
cific protein in the adult [32]. Likewise, the uptake and
secretion of SP-B was demonstrated in the here char-
acterized cells which is uniquely observed in AT2 cells
[19–24]. Release of moderate amounts of phospho-
lipids from these cells was also observed. Finally, ultra-
structural evidence of lamellar bodies implies sufficient
expression of surfactant proteins [32]. Here, the pres-
ence of lamellar bodies was demonstrated by electron
microscopy and by positive stainings for lysotracker, a
marker of differentiated AT2 cells which selectively la-
bels lipid rich lamellar bodies [18].
Conclusion
This study describes a novel method for isolating AT2
cells from human adult lung tissue by sprouting. The
characterization of the cultured AT2 cells complies with
current criteria for an alveolar type 2 cell phenotype.
Compared to current protocols for the culture of AT2
cells, isolating the cells by sprouting is simple and avoids
proteolytic tissue digestion.
Abbreviations
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A: surfactant protein A; SP-B: surfactant protein B; SP-C: surfactant protein
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Fig. 2 (a) Up-take and secretion of labelled surfactant protein B (SP-B) by primary human type II alveolar epithelial (AT2) cells. Labelled SP-B was
added to the cells and a first uptake was observed at 0 min (a a), visualized as green staining in the cytoplasm. Five minutes after addition of a
surfactant secretagogue (1-oleoyl-2-acetyl-sn-glycerol) which stimulates the secretion of SP-B, a decrease in the fluorescence was detected, and
after 15 and 30 min the intensity of fluorescence further diminished (a b-f). (b) Levels of phospholipids (μM) measured in AT2 cell supernatants as
compared to control medium. (c) Quantitative real time RT-PCR for gene expression of surfactant protein A (SP-A), surfactant protein B (SP-B),
surfactant protein C (SP-C), and surfactant protein D (SP-D) by AT2 cells. Relative mRNA expression was normalized to GAPDH. Data are presented
as mean ± SEM of independent experiments performed in four different cell lines. (d) SP-C protein expression in AT2 cells of two different donors
(sample 1 + 2) was determined by western blot. β-actin served as control for equal protein loading. (e) Electron microscopy image of AT2 cells
showing lamellar bodies (arrow)
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